Same-Day Radiation Treatment for Large Liver Cancer
Part of Cancer, Digestive system clinical trials.
This trial tests giving a same-day radiation treatment (radioembolization) for large liver cancers (5 cm or bigger). It might be an option if your liver is still working well and you are in good general health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by biopsy or special scans (LI-RADS 4 or 5).
- Your main liver tumor is 5 cm or larger and has small, twisted blood vessels inside it (3 mm or smaller).
- Your liver is working well (Child-Pugh class A) and you are generally active (ECOG 0 or 1).
- Your blood counts and kidney/liver lab results meet certain safe limits (e.g., platelets at least 40,000, bilirubin no more than 2.0).
- You have not had a stent placed in your bile duct or any surgery connecting your bile duct to your intestine, and you do not have severe lung disease (COPD or interstitial lung disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
This trial tests a targeted internal radiation treatment for people with liver cancer (HCC) that is too widespread for surgery and goes beyond the up-to-7 criteria. It aims to see if this therapy can safely and effectively treat tumors that are all located in a specific area of the liver.
This trial tests two different ways to treat liver cancer that can't be removed with surgery. It compares stereotactic body radiation therapy (targeted high-dose radiation) with selective internal radiation therapy (tiny radioactive beads delivered through a blood vessel), both combined with immunotherapy (medicines that help your immune system fight cancer).
This trial tests a new type of treatment using low-energy radio waves (called electromagnetic fields) for people with advanced liver cancer that can't be removed by surgery. The goal is to see if adding this therapy can help your immune system fight the cancer better.
This trial tests if a targeted radiation treatment, called SIRT, can shrink liver tumors enough to allow for a liver transplant or surgical removal. It is for people with liver cancer who are not yet eligible for these procedures.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.